Form 4: Fulgent Genetics CEO Ming Hsieh Reports Stock Transactions
SEC Form 4 Filing
CEO Ming Hsieh reports disposition of shares to cover tax obligations and details beneficial ownership through trusts and custodial accounts.
Summary
- On August 1, 2024, Ming Hsieh, CEO of Fulgent Genetics, reported a transaction involving common stock.
- 1,337 shares were disposed of to cover tax withholding obligations related to vesting restricted stock units.
- The price per share for the transaction was $23.57.
- Following the transaction, Mr. Hsieh directly owns 709,588 shares.
- Mr. Hsieh also has indirect ownership through the Dynasty Trust (220,816 shares), the Ming Hsieh Trust (7,895,115 shares), and Uniform Transfer to Minors Accounts (2,000 shares).
- Mr. Hsieh disclaims beneficial interest in the Dynasty Trust shares except for any pecuniary interest.
- Mr. Hsieh has sole voting and dispositive power over the shares held by the Hsieh Trust and the Uniform Transfer to Minors Accounts.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 08/01/2022 | Date of restricted stock units grant, originally reported on Form 4 filed August 3, 2022. |
| 08/01/2024 | Date of stock transaction (disposal of shares for tax withholding). |
| 08/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.